Why Do Women Persist With Futile Fertility Treatments | Talya Miron
Summary :
Why are women who face poor prognoses for success in assisted reproductive technology (ART) treatment choosing to pursue procedures using their own eggs, despite receiving information that their chances of success are low? Cross-sectional study based on an anonymous questionnaire distributed to women aged between 43 and 45 years, undergoing ART using their own oocytes, at public outpatient fertility clinics and public in-hospital IVF units in Israel. The main outcome measure was personal estimation of chance to achieve a live birth after the current ART treatment cycle and the cumulative estimated rate after all the treatment cycles the patient intended to undergo.
About Author :
Talya Miron-Shatz (PhD psychology) is full professor at the Ono Academic College, Israel, and visiting researcher at the University of Cambridge. She specializes in studying health and medical decisions, with over 60 academic papers on the topic. She also has vast industry experience as a consultant to pharma, health advertisers, startups and corporates. Prof. Miron-Shatz did her post-doc at Princeton University with Nobel laureate Daniel Kahneman, taught at Wharton, and is a visiting researcher at Cambridge University. She is the author of ‘Your Life Depends On It: What You Can Do to Make Better Choices about Your Health (Basic Books, Hachette).
